Company intelligence / Profile preview

Quadria Capital

Singapore, Singapore, Singapore

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Quadria Capital is Asia's leading healthcare private equity firm managing over $4 billion in AUM, investing in innovative companies spanning healthcare delivery, life sciences, medical devices, and associated services across South Asia and Southeast Asia; its portfolio companies deliver affordable, high-quality healthcare, manufacture thousands of generic drugs, and serve millions of patients annually.

Industry: Investors

Partnerships

Blue Earth Capital (impact investor, ESG, and strategic operational partnership)IFC (International Finance Corporation, investor)

Beyond the preview

Go deeper on Quadria Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quadria Capital.

Explore the full profile